A POTENTIAL USE OF THE NATIONAL DEATH INDEX FOR POSTMARKETING DRUG SURVEILLANCE

被引:10
作者
EDLAVITCH, SA
FEINLEIB, M
ANELLO, C
机构
[1] US FDA,NATL CTR DRUGS & BIOL,DIV DRUG & BIOL PROD EXPERIENCE,ROCKVILLE,MD 20857
[2] US FDA,NATL CTR DRUGS & BIOL,DIV BIOMETR,ROCKVILLE,MD 20857
[3] NATL CTR HLTH STAT,HYATTSVILLE,MD 20782
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1985年 / 253卷 / 09期
关键词
D O I
10.1001/jama.253.9.1292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1292 / 1295
页数:4
相关论文
共 4 条
[1]  
LUBITZ J, 1984, 112TH ANN AM PUBL HL
[2]   ANALYSIS OF RELATIVE SURVIVAL AND PROPORTIONAL MORTALITY [J].
MONSON, RR .
COMPUTERS AND BIOMEDICAL RESEARCH, 1974, 7 (04) :325-332
[3]   AN EVALUATION OF THE SOCIAL-SECURITY-ADMINISTRATION MASTER BENEFICIARY RECORD FILE AND THE NATIONAL-DEATH-INDEX IN THE ASCERTAINMENT OF VITAL STATUS [J].
WENTWORTH, DN ;
NEATON, JD ;
RASMUSSEN, WL .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1983, 73 (11) :1270-1274
[4]  
1981, PHS811148 US DEP HLT